Cornelia Wurzenberger

549 total citations
11 papers, 429 citations indexed

About

Cornelia Wurzenberger is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Cornelia Wurzenberger has authored 11 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Cornelia Wurzenberger's work include Immune Cell Function and Interaction (6 papers), Immune Response and Inflammation (6 papers) and Immunotherapy and Immune Responses (5 papers). Cornelia Wurzenberger is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Immune Response and Inflammation (6 papers) and Immunotherapy and Immune Responses (5 papers). Cornelia Wurzenberger collaborates with scholars based in Germany. Cornelia Wurzenberger's co-authors include David Anz, Stefan Endres, Carole Bourquin, Nadja Sandholzer, Michaela Golić, Anna-Lisa Lanz, Conrad Coester, Sebastian Fuchs, Gerhard Winter and Philip von der Borch and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Cornelia Wurzenberger

11 papers receiving 420 citations

Peers

Cornelia Wurzenberger
Christopher Schliehe Netherlands
Deeksha Deep United States
Mariana Pereira Pinho Brazil
Anne‐Laure Puaux France
Ines Mende United States
Zhunyi Xie China
Yang Pu China
Soung-Chul Cha United States
Hong Wan United States
Yolanda C. Nesbeth United States
Christopher Schliehe Netherlands
Cornelia Wurzenberger
Citations per year, relative to Cornelia Wurzenberger Cornelia Wurzenberger (= 1×) peers Christopher Schliehe

Countries citing papers authored by Cornelia Wurzenberger

Since Specialization
Citations

This map shows the geographic impact of Cornelia Wurzenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Wurzenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Wurzenberger more than expected).

Fields of papers citing papers by Cornelia Wurzenberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia Wurzenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Wurzenberger. The network helps show where Cornelia Wurzenberger may publish in the future.

Co-authorship network of co-authors of Cornelia Wurzenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelia Wurzenberger. A scholar is included among the top collaborators of Cornelia Wurzenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelia Wurzenberger. Cornelia Wurzenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wurzenberger, Claudia, Cornelia Wurzenberger, Stefan Grüner, et al.. (2021). Development of PRS-220, a potential best-in-class, inhaled CTGF/CCN2 inhibitor for the treatment of IPF. PA732–PA732. 3 indexed citations
2.
Anz, David, Moritz Rapp, Stephan Eiber, et al.. (2015). Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression. Cancer Research. 75(21). 4483–4493. 63 indexed citations
3.
Endell, Jan, Rainer Boxhammer, Cornelia Wurzenberger, Daniel Ness, & Stefan Steidl. (2012). The Activity of MOR202, a Fully Human Anti-CD38 Antibody, Is Complemented by ADCP and Is Synergistically Enhanced by Lenalidomide in Vitro and in Vivo. Blood. 120(21). 4018–4018. 31 indexed citations
4.
Bourquin, Carole, C. Hotz, Daniel Noerenberg, et al.. (2011). Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance. Cancer Research. 71(15). 5123–5133. 68 indexed citations
5.
Bourquin, Carole, Cornelia Wurzenberger, Simon Heidegger, et al.. (2010). Delivery of Immunostimulatory RNA Oligonucleotides by Gelatin Nanoparticles Triggers an Efficient Antitumoral Response. Journal of Immunotherapy. 33(9). 935–944. 26 indexed citations
6.
Bourquin, Carole, Philip von der Borch, David Anz, et al.. (2010). Efficient Eradication of Subcutaneous but Not of Autochthonous Gastric Tumors by Adoptive T Cell Transfer in an SV40 T Antigen Mouse Model. The Journal of Immunology. 185(4). 2580–2588. 15 indexed citations
7.
Bourquin, Carole, Laura S. Schmidt, Anna-Lisa Lanz, et al.. (2009). Immunostimulatory RNA Oligonucleotides Induce an Effective Antitumoral NK Cell Response through the TLR7. The Journal of Immunology. 183(10). 6078–6086. 33 indexed citations
8.
Bourquin, Carole, David Anz, Anna-Lisa Lanz, et al.. (2008). Targeting CpG Oligonucleotides to the Lymph Node by Nanoparticles Elicits Efficient Antitumoral Immunity. The Journal of Immunology. 181(5). 2990–2998. 125 indexed citations
9.
Wurzenberger, Cornelia, Viktor H. Koelzer, S. Schreiber, et al.. (2008). Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo. Cancer Immunology Immunotherapy. 58(6). 901–913. 12 indexed citations
10.
Wurzenberger, Cornelia. (2008). Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München Dendritic cell vaccines in tumor immunotherapy: Immune activation strategies with ligands for the Toll-like receptors 7 and 9. 1 indexed citations
11.
Bourquin, Carole, Laura S. Schmidt, Veit Hornung, et al.. (2006). Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response. Blood. 109(7). 2953–2960. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Schliehe Breakdown of academic impact, for papers by Deeksha Deep Breakdown of academic impact, for papers by Mariana Pereira Pinho Breakdown of academic impact, for papers by Anne‐Laure Puaux Breakdown of academic impact, for papers by Ines Mende Breakdown of academic impact, for papers by Zhunyi Xie Breakdown of academic impact, for papers by Yang Pu Breakdown of academic impact, for papers by Soung-Chul Cha Breakdown of academic impact, for papers by Hong Wan Breakdown of academic impact, for papers by Yolanda C. Nesbeth
Rankless by CCL
2026